Chitnis Amit S, Schecter Gisela F, Cilnis Martin, Robsky Katherine, Flood Jennifer M, Barry Pennan M
Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, Calif., USA.
Am J Nephrol. 2014;39(4):314-21. doi: 10.1159/000360183. Epub 2014 Apr 15.
BACKGROUND/AIMS: Few studies have compared population-based tuberculosis (TB) incidence rates by end-stage renal disease (ESRD) status. No studies have compared TB genotypes by ESRD status to determine whether TB disease resulted from recent transmission or reactivation of latent TB infection (LTBI). We calculated TB incidence rates and compared demographic and clinical characteristics and genotypes among TB cases by ESRD status.
This analysis was based on prospective surveillance for TB cases during 2010 in California. Clustered genotype was defined as ≥2 culture-positive TB cases with matching genotypes in the same county. The χ(2) or Wilcoxon rank-sum test was used to compare variables.
During 2010, 83 TB cases with ESRD and 2,244 cases without ESRD were reported in California; TB incidence rates were 110.3/100,000 and 6.0/100,000, respectively. ESRD case patients versus patients without ESRD were more likely to be older (median age 66 vs. 49 years; p < 0.001), foreign-born persons who had arrived in the USA >5 years before TB diagnosis (97 vs. 75%; p < 0.001) and dead at TB diagnosis (7 vs. 2%; p = 0.01). ESRD patients were less likely to have a positive tuberculin skin test (50 vs. 80%; p < 0.001), positive acid-fast bacilli sputum smears (33 vs. 53%; p = 0.01) and cavities on chest radiography (6 vs. 21%; p = 0.01). No differences in proportions of clustered TB genotypes were detected (20 vs. 23%; p = 0.54).
Rates of TB are 18 times higher in California's ESRD population, and TB disease likely occurred due to LTBI reactivation because few patients had clustered genotypes. Efforts to prevent TB among ESRD patients may require the use of newer diagnostic tests and promotion of LTBI treatment.
背景/目的:很少有研究比较基于人群的终末期肾病(ESRD)状态的结核病(TB)发病率。尚无研究比较ESRD状态下的TB基因型,以确定TB疾病是由近期传播还是潜伏性结核感染(LTBI)的重新激活所致。我们计算了TB发病率,并比较了不同ESRD状态的TB病例的人口统计学和临床特征及基因型。
本分析基于2010年加利福尼亚州对TB病例的前瞻性监测。聚集基因型定义为在同一县内≥2例培养阳性且基因型匹配的TB病例。采用χ²检验或Wilcoxon秩和检验比较变量。
2010年,加利福尼亚州报告了83例ESRD相关TB病例和2244例非ESRD相关病例;TB发病率分别为110.3/10万和6.0/10万。与非ESRD患者相比,ESRD患者更可能年龄较大(中位年龄66岁对49岁;p<0.001),是在TB诊断前>5年抵达美国的外国出生者(97%对75%;p<0.001),且在TB诊断时已死亡(7%对2%;p=0.01)。ESRD患者结核菌素皮肤试验阳性的可能性较小(50%对80%;p<0.001),痰涂片抗酸杆菌阳性的可能性较小(33%对53%;p=0.01),胸部X线有空洞的可能性较小(6%对21%;p=0.01)。未检测到聚集性TB基因型比例的差异(20%对23%;p=0.54)。
加利福尼亚州ESRD人群中的TB发病率高18倍,且由于很少有患者具有聚集性基因型,TB疾病可能是由LTBI重新激活所致。预防ESRD患者TB的努力可能需要使用更新的诊断测试并促进LTBI治疗。